The awards for drug pricing cognitive dissonance

In response to that pending Trump administration rule that would force drug companies to put prices in ads, a bunch of companies volunteered to create websites that would explain what patients might actually pay for their products.

And then things got strange.

As STAT’s Nicholas Florko discovered, the resulting websites employed oversimplifications, cunning use of fine print, and a lot of reminders of just how complicated it is to define “the price of a drug” in 2019. And then he handed out awards for transparency and its opposite.

Read more.